by Caroline Helwick
San Francisco—New-generation stool DNA testing for colorectal cancer (CRC) screening offers “extraordinarily” high detection rates for cancers and precancers that are likely to progress, said David Ahlquist, MD, professor of medicine, Department of Gastroenterology and Hepatology at the Mayo Clinic, Rochester, Minn., who helped develop this approach and presented recent findings at the 2012 American...